- Clinical Trials
- April 2024
- 80 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1202EUR$1,250USD£1,031GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1202EUR$1,250USD£1,031GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- February 2024
- 125 Pages
From €4087EUR$4,250USD£3,506GBP
- Report
- May 2019
- 77 Pages
Global
From €2788EUR$2,900USD£2,392GBP
- Clinical Trials
- October 2020
- 893 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Clinical Trials
- June 2020
- 156 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Clinical Trials
- June 2020
- 817 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Drug Pipelines
- January 2022
- 84 Pages
Global
From €6726EUR$6,995USD£5,770GBP
- Drug Pipelines
- October 2020
- 151 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Drug Pipelines
- July 2020
- 113 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- May 2023
- 85 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- July 2022
- 86 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Drug Pipelines
- March 2021
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- May 2022
- 36 Pages
Global
From €1923EUR$2,000USD£1,650GBP
Esophagitis is a condition that affects the esophagus, the tube that connects the throat to the stomach. It is caused by inflammation of the esophagus due to acid reflux, infection, or other irritants. Treatment for esophagitis typically involves medications that reduce acid production, reduce inflammation, and promote healing. These medications are part of the gastrointestinal drug market, which includes drugs used to treat a variety of gastrointestinal conditions.
Esophagitis drugs are typically divided into two categories: antacids and proton pump inhibitors (PPIs). Antacids are used to neutralize stomach acid and provide relief from heartburn and other symptoms of esophagitis. PPIs are used to reduce the amount of acid produced by the stomach, which can help reduce inflammation and promote healing.
The esophagitis drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AstraZeneca, Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more